Stay updated on Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial
Sign up to get notified when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.

Latest updates to the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page
- Check6 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center status with a link to opm.gov for updates, and updated the revision from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check13 days agoChange DetectedUI and footer metadata updates: added a 'Show glossary' label, corrected capitalization of 'Last Update Submitted that Met QC Criteria', and updated the footer to include 'No FEAR Act Data' and 'Revision: v3.4.0'.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedSoftware template revision updated from v3.3.3 to v3.3.4. No study content or user-facing layout changes are apparent.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page adds a Revision: v3.3.3 label and removes the HHS Vulnerability Disclosure and Revision: v3.3.2 links from the footer. These are administrative site updates with no impact on study content or user interaction.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision indicator updated from v3.3.1 to v3.3.2 on the page footer, with no observed changes to study details, eligibility criteria, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check77 days agoChange DetectedPublications section now notes that entries are automatically filled from PubMed and may not all relate to the study. The page revision has been updated to v3.3.1.SummaryDifference0.1%

Stay in the know with updates to Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.